Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMR vaccine for prevention of COVID-19 in healthcare personnel
IRCT20200802048266N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of measles, mumps, and rubella vaccine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Incidence of COVID-19. Started Nov 2020; status: completed.
02
Drugs
measles, mumps, and rubella vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200802048266N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200802048266N1.